Webinar #1
CMS Proposed Rule for Value-Based Purchasing
Tuesday, October 6, 2020 | 11:00 a.m. – 12:00 p.m. EDT | $49
The CMS Proposed Rule filed in June 2020 could transform the way Medicaid treats Value-Based Purchasing Arrangements and line extensions. This presentation will explore the changes that could be made if the regulation is finalized.
Learn more about the speakers below.
George Kitchens RPH
Chief Executive Officer,
Senior Partner
Artia Solutions
George founded Artia Solutions, LLC, in 2005. For more than a decade, George ensures that Artia provides top-notch consultation services to clients needing assistance in operating within the Medicaid pharmaceutical environment. Prior to his recent consulting services, George was Vice President of Business Development for Provider Synergies, a company managing rebate programs for state Medicaid. Read More…
Jackie Menzel JD, MIS
Consultant, Legislation and Policy
Artia Solutions
Jackie Menzel is the Legislative and Policy Consultant for Artia Solutions. She acts as Artia’s internal advisor on legislative, regulatory, and policy changes impacting Artia’s clients at both the federal and state level. Jackie reports on policy updates in The Advantage, Medicaid in the News and deep dive client presentations. She also provides guidance to clients to ensure their strategies account for current and future policy changes. Prior to working for Artia Solutions, Jackie provided guidance and research expertise for AmLaw200 firms with clients in the pharmaceutical and life sciences industry. This included working on matters of litigation, intellectual property, transactional services as well as regulation and policy from CMS, HHS, FDA and the USPTO. She graduated from Florida State University School of Law in 2012.
Webinar #2
Sickle Cell Disease Update with a Physician’s Perspective
Wednesday, October 7, 2020 | 4:00 – 5:00 p.m. EDT | $49
Hear from experts Ahmar Zaidi, MD, and Wanda Whitten-Shurney, MD, for the history and challenges of treating sickle cell disease, as well as the latest updates on L-glutamine, crizanlizumab, voxelotor, and gene therapy.
Learn more about the speakers below.
Ahmar U. Zaidi,
MD
Assistant Professor of Pediatrics
Division of Pediatric Hematology/Oncology
Central Michigan University School of Medicine
Wayne State University School of Medicine
Comprehensive Sickle Cell Center
Children’s Hospital of Michigan
Dr. Zaidi is a classical hematologist who cares for chronic and acquired hemolytic anemias, and hemoglobinopathies, primarily, sickle cell disease (SCD). His research interests are focused on the intersection of technology and disease, as well as on healthcare outcomes and novel biomarker development. He is also a tireless advocate for sickle cell disease and firmly believes that advocacy and patient education can be achieved using social media as a tool to interact with patients and physicians.
Twitter/Instagram: @drzsicklecell
Wanda Whitten-Shurney MD
CEO and Medical Director
Sickle Cell Disease Association of America, Michigan Chapter (SCDAAMI)
Dr. Wanda Whitten-Shurney is currently the CEO and Medical Director for the Sickle Cell Disease Association of America, Michigan Chapter (SCDAAMI.) The mission of the organization is to maximize the quality of life of individuals living with sickle cell disease, educate the public and help young people who are at risk for having a child with sickle cell disease make informed decisions with respect to family planning. She is also a pediatrician at the Comprehensive Sickle Cell Clinic at Children’s Hospital of Michigan where she has provided compassionate care for children with sickle cell disease for over 30 years. She has a particular interest in patient education and providing coping strategies for families once they learn of their baby’s condition. Read More…
Webinar #3
Safety, Legal, and Evidentiary Challenges of Cannabis-Based Products
Tuesday, October 13, 2020 | 1:00 – 2:00 p.m. EDT | $49
Cannabis has been the focus of considerable debate, advocacy, and policy, generating both interest and misinformation. This presentation will provide an overview of cannabis and cannabinoid terminology, current regulations, describe the existing body of evidence that informs current understanding of the potential therapeutic benefits and harms associated with cannabis use, and how that evidence measures up to established evidence-based standards employed by health insurers’ in their technology assessment and coverage processes, and share web-based resources available for continued learning.
Learn more about the speakers below.
Dr. Jennifer L. Triemstra MS, PhD
Associate Director, Medical Affairs
Cannabinoid Education
Jennifer, also known as, “Trie,” is the Senior Manager of Cannabinoid Education for Greenwich Biosciences. Prior to her current role, Trie was a Medical Science Liaison at Greenwich Biosciences providing scientific support to develop an FDA-approved cannabidiol therapy for the treatment of seizures associated with epilepsy. Trie received her Masters of Science from State Cloud State University and her PhD at the University of Minnesota. Before graduate school, she spent several years working in academia performing laboratory research focused on neuroendocrinology. She currently lives in Minneapolis with her spouse, 2 children, and a fish named ‘Pete.’
Wade M. Aubry MS, PhD
Clinical Professor of Medicine and Health Policy
University of California, San Francisco
Dr. Aubry is Clinical Professor of Medicine and Core Faculty at the UCSF Institute for Health Policy Studies, where his research focuses on technology assessment, Medicare and commercial health plan coverage decisions, and quality measurement. He is a former Blue Cross Blue Shield and Medicare Medical Director, a former Chair of the national BCBSA Technology Assessment Committee, and a former member of the Medicare Coverage Advisory Committee for national coverage decisions in Medicare. He has also served on numerous national health care advisory committees for NIH, AHRQ, NCQA, and the National Academy of Medicine. Dr. Aubry is a graduate of Stanford and the UCLA School of Medicine. Trained as an internist and endocrinologist at Cedars-Sinai Medical Center, he practiced medicine in San Francisco and served as Chief of Staff at Saint Francis Hospital. He has numerous publications on technology assessment, coverage decisions, and health care quality.
Webinar #4
Covid-19 Impact on Medicaid Enrollment
Wednesday, October 14, 2020 | 2:00 p.m. – 2:45 p.m. EDT | $49
Medicaid enrollment is certainly growing, but what exactly does it look like? This session will compare Medicaid enrollment from pre-COVID-19 levels to current levels, and will identify trends overall, by state, and within the Fee for Service (FFS) and Medicaid Managed Care (MMC) market segments. It will also provide insights on how state budgets could impact Medicaid programs, the services they provide, and coverage of drug manufacturer’s medications.
Learn more about the speakers below.
Eric Kimelblatt
Senior Director, Managed Markets
Artia Solutions
Eric is currently the Senior Director of Managed Markets, working with clients to effectively capitalize on opportunities and overcome challenges with Payers and PBMs in the Medicaid Managed Care, Medicare Part D and Commercial markets.
Eric’s entire career has been focused on the government and commercial payer markets from a pharmaceutical manufacturer perspective, with a concentration on managed markets strategy, access/reimbursement, account management, pricing/contracting, patient support and product distribution. Read More…
Kim Eggert RPh
Senior Manager, Managed Markets
Artia Solutions
Kim is currently Senior Manager of Managed Markets working with Eric in helping clients understand the intricacies of the Medicaid Managed Care market structure and landscape and developing the best strategy for securing favorable access and reimbursement in this complex and ever-evolving market. She is a true expert at researching Medicaid Managed Care plans to document and interpret policies, procedures, and reactions to products (new launches and existing), while uncovering trends and identifying areas of concern for her clients. Read More…
Kinsey Caldwell
Director, Analytics
Artia Solutions
Kinsey currently serves as Director of Analytics for Artia Solutions. She supports clients with all financial aspects of the Medicaid rebate process, optimizing the accessibility of pharmaceuticals in the Medicaid marketplace. Resources managed by Kinsey include Supplemental Rebate Analyses/Tracking, Predictive Rebate Modeling, and Artia App’s Market Share functionality. She also assists clients with the ever-changing landscape of Medicaid policy to help develop strategies that will overcome potential barriers after launch.
Kinsey graduated with a Bachelor of Science degree in statistics with a focus on mathematics and economics in 2014 from the Florida State University College of Arts and Sciences. She also received the SAS Programming and Data Analysis Certificate.
Celebrate!
Extra Mile Award Celebration
Thursday, October 15, 2020 | 4:00 p.m. – 4:30 p.m. EDT | Complimentary
You’re invited! Please join us for a virtual Extra Mile Award celebration, where we will announce the 2020 Extra Mile Award recipients. A cocktail/mocktail recipe and fun surprises are coming!
register today!
Thank you to our sponsors and advertisers!
We're announcing our fall webinar series VERY soon! 💡Sign up for our email list to be the first to know: https://buff.ly/2I6PPsU
The South Carolina Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Continuing education credits will be available to participants who fully attend the program and then complete an online educational activity evaluation. A unique code given at each activity must be provided in the evaluation to receive credit. Grievances regarding the education program must be submitted in writing to the SCPhA ACPE Administrator immediately following the program.
